Gene · 4048
Papers1,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular screening in a translational large animal trial identifies a differential inflammatory response for MINOCA. | Basic Res Cardiol | 2025 | 40512240 | PubTator, text mining | PubMed |
| Microscale Proteomic Analysis of the Endolymphatic Sac in Menière's Disease Patients. | Otol Neurotol | 2025 | 40062362 | PubTator, text mining | PubMed |
| LTA4H improves the tumor microenvironment and prevents HCC progression via targeting the HNRNPA1/LTBP1/TGF-β axis. | Cell Rep Med | 2025 | 40056904 | PubTator, text mining | PubMed |
| Alpha-Lipoic Acid-Mediated Inhibition of LTB4 Synthesis Suppresses Epithelial-Mesenchymal Transition, Modulating Functional and Tumorigenic Capacities in Non-Small Cell Lung Cancer A549 Cells. | Curr Ther Res Clin Exp | 2025 | 39816494 | PubTator, text mining | PubMed |
| Advancing the chemotherapy of tuberculous meningitis: a consensus view. | Lancet Infect Dis | 2025 | 39342951 | PubTator, text mining | PubMed |
| Validation of endoplasmic reticulum stress-related gene signature to predict prognosis and immune landscape of patients with non-small cell lung cancer. | Technol Health Care | 2025 | 39331119 | PubTator, text mining | PubMed |
Statistical analysis plan for the LAST ACT clinical trial; a Leukotriene A4 hydrolase Stratified non-inferiority Trial of Adjunctive Corticosteroids for HIV-negative adults with Tuberculous meningitis. | Wellcome Open Res | 2024 | 39911285 | PubTator, text mining | PubMed |
| Identification of mitophagy-related key genes and their correlation with immune cell infiltration in acute myocardial infarction via bioinformatics analysis. | Front Cardiovasc Med | 2024 | 39872885 | PubTator, text mining | PubMed |
| Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals. | Front Immunol | 2024 | 39717773 | PubTator, text mining | PubMed |
| Uses of Molecular Docking Simulations in Elucidating Synergistic, Additive, and/or Multi-Target (SAM) Effects of Herbal Medicines. | Molecules | 2024 | 39598795 | PubTator, text mining | PubMed |
| Aspergillus fumigatus-derived gliotoxin impacts innate immune cell activation through modulating lipid mediator production in macrophages. | Immunology | 2024 | 39268960 | PubTator, text mining | PubMed |
| Pattern of Expression of Genes Involved in Systemic Inflammation and Glutathione Metabolism Reveals Exacerbation of COPD. | Antioxidants (Basel) | 2024 | 39199199 | PubTator, text mining | PubMed |
| Airway extracellular LTA4H concentrations are governed by release from liver hepatocytes and changes in lung vascular permeability. | Cell Rep | 2024 | 39146180 | PubTator, text mining | PubMed |
| [Mechanism of Puerariae Thomsonii Radix in treatment of mild dyslipidemia: based on clinical metabolomics and proteomics]. | Zhongguo Zhong Yao Za Zhi | 2024 | 38812181 | PubTator, text mining | PubMed |
| Zerumbone exhibits anti-inflammatory effects by suppressing eicosanoid signaling: Evidence from LPS-induced peripheral blood leukocytes. | Prostaglandins Other Lipid Mediat | 2024 | 38761959 | PubTator, text mining | PubMed |
| Recent Advances in Automated Structure-Based De Novo Drug Design. | J Chem Inf Model | 2024 | 38485516 | PubTator, text mining | PubMed |
| Structure-Guided Elaboration of a Fragment-Like Hit into an Orally Efficacious Leukotriene A4 Hydrolase Inhibitor. | J Med Chem | 2024 | 38476002 | PubTator, text mining | PubMed |
| LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial. | Clin Transl Sci | 2024 | 38407540 | PubTator, text mining | PubMed |
| Neutrophil elastase-dependent cleavage of LTA4H alters its aminopeptidase activity in cystic fibrosis. | Eur Respir J | 2024 | 38387968 | PubTator, text mining | PubMed |
| Evaluation of penalized and machine learning methods for asthma disease prediction in the Korean Genome and Epidemiology Study (KoGES). | BMC Bioinformatics | 2024 | 38308205 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4048/papers?page=3